Product Information:
AcrySof® IQ Toric IOLs


The proven performance of AcrySof® IQ Toric IOLs can allow your astigmatic cataract patients to meet their vision goals with less dependence on glasses or contacts for distance vision.1,2

More than nine out of 10 cataract patients achieve distance vision of 20/40 or better

Treat a Wide Range of Patients

AcrySof® IQ Toric IOLs offer spherical powers in half diopter increments from +6.0 D to +34.0 D and seven cylinder powers to treat 0.75 D to 4.11 D and greater of preexisting corneal astigmatism.

The Platform You Trust

AcrySof® IQ Toric IOLs are built on the industry-leading* AcrySof® IQ IOL platform offering BioMaterial, BioMechanics and BioOptics benefits for you and your patients. Plus they are designed to reduce distance-vision spectacle dependence for your astigmatic patients.1,2

Connect the dots mastering toric IOL resource center

Toric IOL Advantages

  • Highly reliable treatment method2,3
  • Better post-op outcomes†,2-4
  • Reduced residual refractive cylinder†,1-4
  • More freedom from glasses for distance†,1-3
  • Better bilateral uncorrected visual acuity†,2
  • More effective and predictable compared to corneal relaxing incisions3


Distance spectacle wear six months post-surgery after second eye2

Select an IOL below the chart to compare distance spectacle-wear rates. Click again to hide or reveal the data.

The majority of patients with AcrySof® IQ Toric IOL implants report using distance vision glasses none of the time
  • AcrySof® IQ Toric IOL (n=37)
  • AcrySof® Single-Piece IOL (SA60AT) (n=22)

Nearly 100% of AcrySof® IQ Toric IOL patients reported needing spectacles for distance vision “none of the time.” Data were not available for three patients with AcrySof® IQ Toric IOLs.

In the 37-patient subset of the AcrySof® IQ Toric IOL clinical trial, more than 97% of patients bilaterally implanted with AcrySof® IQ Toric IOL reported using spectacles "none of the time."2

Study included AcrySof® IQ Toric IOL (n=37) and AcrySof® single-piece IOL model SA60AT (n=22).2


*Market Scope Annual Report, 2014.
Compared to a monofocal IOL.

View Important Product Information for
AcrySof® IQ Toric IOL+

ACRYSOF® IQ TORIC INTRAOCULAR LENSES IMPORTANT PRODUCT INFORMATION

CAUTION: Federal (USA) law restricts this device to the sale by or on the order of a physician.

INDICATIONS: The AcrySof® IQ Toric posterior chamber intraocular lenses are intended for primary implantation in the capsular bag of the eye for visual correction of aphakia and pre-existing corneal astigmatism secondary to removal of a cataractous lens in adult patients with or without presbyopia, who desire improved uncorrected distance vision, reduction of residual refractive cylinder and increased spectacle independence for distance vision.

WARNINGS/PRECAUTIONS: Careful preoperative evaluation and sound clinical judgment should be used by the surgeon to decide the risk/benefit ratio before implanting a lens in a patient with any of the conditions described in the Directions for Use labeling. Toric IOLs should not be implanted if the posterior capsule is ruptured, if the zonules are damaged, or if a primary posterior capsulotomy is planned. Rotation can reduce astigmatic correction; if necessary lens repositioning should occur as early as possible prior to lens encapsulation. All viscoelastics should be removed from both the anterior and posterior sides of the lens; residual viscoelastics may allow the lens to rotate.

Optical theory suggests that high astigmatic patients (i.e., > 2.5 D) may experience spatial distortions. Possible toric IOL related factors may include residual cylindrical error or axis misalignments. Prior to surgery, physicians should provide prospective patients with a copy of the Patient Information Brochure available from Alcon for this product informing them of possible risks and benefits associated with the AcrySof® IQ Toric Cylinder Power IOLs.

Studies have shown that color vision discrimination is not adversely affected in individuals with the AcrySof® Natural IOL and normal color vision. The effect on vision of the AcrySof® Natural IOL in subjects with hereditary color vision defects and acquired color vision defects secondary to ocular disease (e.g., glaucoma, diabetic retinopathy, chronic uveitis, and other retinal or optic nerve diseases) has not been studied. Do not resterilize; do not store over 45° C; use only sterile irrigating solutions such as BSS® or BSS PLUS® Sterile Intraocular Irrigating Solutions.

ATTENTION: Reference the Directions for Use labeling for a complete listing of indications, warnings and precautions.

Click here to view the AcrySof® IQ Toric IOL Directions for Use (DFU).

ACRYSOF® IQ TORIC INTRAOCULAR LENSES IMPORTANT PRODUCT INFORMATION

CAUTION: Federal (USA) law restricts this device to the sale by or on the order of a physician.

INDICATIONS: The AcrySof® IQ Toric posterior chamber intraocular lenses are intended for primary implantation in the capsular bag of the eye for visual correction of aphakia and pre-existing corneal astigmatism secondary to removal of a cataractous lens in adult patients with or without presbyopia, who desire improved uncorrected distance vision, reduction of residual refractive cylinder and increased spectacle independence for distance vision.

WARNINGS/PRECAUTIONS: Careful preoperative evaluation and sound clinical judgment should be used by the surgeon to decide the risk/benefit ratio before implanting a lens in a patient with any of the conditions described in the Directions for Use labeling. Toric IOLs should not be implanted if the posterior capsule is ruptured, if the zonules are damaged, or if a primary posterior capsulotomy is planned. Rotation can reduce astigmatic correction; if necessary lens repositioning should occur as early as possible prior to lens encapsulation. All viscoelastics should be removed from both the anterior and posterior sides of the lens; residual viscoelastics may allow the lens to rotate.

Optical theory suggests that high astigmatic patients (i.e., > 2.5 D) may experience spatial distortions. Possible toric IOL related factors may include residual cylindrical error or axis misalignments. Prior to surgery, physicians should provide prospective patients with a copy of the Patient Information Brochure available from Alcon for this product informing them of possible risks and benefits associated with the AcrySof® IQ Toric Cylinder Power IOLs.

Studies have shown that color vision discrimination is not adversely affected in individuals with the AcrySof® Natural IOL and normal color vision. The effect on vision of the AcrySof® Natural IOL in subjects with hereditary color vision defects and acquired color vision defects secondary to ocular disease (e.g., glaucoma, diabetic retinopathy, chronic uveitis, and other retinal or optic nerve diseases) has not been studied. Do not resterilize; do not store over 45° C; use only sterile irrigating solutions such as BSS® or BSS PLUS® Sterile Intraocular Irrigating Solutions.

ATTENTION: Reference the Directions for Use labeling for a complete listing of indications, warnings and precautions.

Click here to view the AcrySof® IQ Toric IOL Directions for Use (DFU).